Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-07

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approves a ketorolac tromethamine product from Fresenius Kabi USA, LLC under an original application for short-term management of acute pain, including post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)